Literature DB >> 21334567

Mapping cortical morphology in youth with velocardiofacial (22q11.2 deletion) syndrome.

Wendy R Kates1, Ravi Bansal, Wanda Fremont, Kevin M Antshel, Xuejun Hao, Anne Marie Higgins, Jun Liu, Robert J Shprintzen, Bradley S Peterson.   

Abstract

OBJECTIVE: Velocardiofacial syndrome (VCFS; 22q11.2 deletion syndrome) represents one of the highest known risk factors for schizophrenia. Insofar as up to 30% of individuals with this genetic disorder develop schizophrenia, VCFS constitutes a unique, etiologically homogeneous model for understanding the pathogenesis of schizophrenia.
METHOD: Using a longitudinal, case-control design, anatomic magnetic resonance images were acquired to investigate cross-sectional and longitudinal alterations in surface cortical morphology in a cohort of adolescents with VCFS and age-matched typical controls. All participants were scanned at two time points.
RESULTS: Compared with controls, youth with VCFS exhibited alterations in inferior frontal, dorsal frontal, occipital, and cerebellar brain regions at both time points. Little change was observed over time in surface morphology of either study group. However, within the VCFS group only, worsening psychosocial functioning over time was associated with time 2 surface contractions in left middle and inferior temporal gyri. Further, prodromal symptoms at time 2 were associated with surface contractions in the left and right orbitofrontal, temporal, and cerebellar regions and surface protrusions of the supramarginal gyrus.
CONCLUSIONS: These findings advance the understanding of cortical disturbances in VCFS that produce vulnerability for psychosis in this high-risk population.
Copyright © 2011 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334567      PMCID: PMC3078574          DOI: 10.1016/j.jaac.2010.12.002

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  64 in total

1.  Hippocampal volume reduction in 22q11.2 deletion syndrome.

Authors:  Martin Debbané; Marie Schaer; Riaz Farhoumand; Bronwyn Glaser; Stephan Eliez
Journal:  Neuropsychologia       Date:  2006-06-19       Impact factor: 3.139

2.  The role of the basal ganglia and cerebellum in language processing.

Authors:  James R Booth; Lydia Wood; Dong Lu; James C Houk; Tali Bitan
Journal:  Brain Res       Date:  2006-12-26       Impact factor: 3.252

3.  Hippocampus and amygdala morphology in attention-deficit/hyperactivity disorder.

Authors:  Kerstin J Plessen; Ravi Bansal; Hongtu Zhu; Ronald Whiteman; Jose Amat; Georgette A Quackenbush; Laura Martin; Kathleen Durkin; Clancy Blair; Jason Royal; Kenneth Hugdahl; Bradley S Peterson
Journal:  Arch Gen Psychiatry       Date:  2006-07

4.  Statistical analyses of brain surfaces using Gaussian random fields on 2-D manifolds.

Authors:  Ravi Bansal; Lawrence H Staib; Dongrong Xu; Hongtu Zhu; Bradley S Peterson
Journal:  IEEE Trans Med Imaging       Date:  2007-01       Impact factor: 10.048

5.  Brain and behaviour in children with 22q11.2 deletion syndrome: a volumetric and voxel-based morphometry MRI study.

Authors:  Linda E Campbell; Eileen Daly; Fiona Toal; Angela Stevens; Rayna Azuma; Marco Catani; Virginia Ng; Therese van Amelsvoort; Xavier Chitnis; William Cutter; Declan G M Murphy; Kieran C Murphy
Journal:  Brain       Date:  2006-03-28       Impact factor: 13.501

6.  Neuromotor deficits in children with the 22q11 deletion syndrome.

Authors:  Christina Sobin; Samantha H Monk; Karen Kiley-Brabeck; Jananne Khuri; Maria Karayiorgou
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

7.  Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome.

Authors:  Kathryn Eve Lewandowski; Vandana Shashi; Peggy M Berry; Thomas R Kwapil
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-01-05       Impact factor: 3.568

8.  ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome.

Authors:  Kevin M Antshel; Wanda Fremont; Nancy J Roizen; Robert Shprintzen; Anne Marie Higgins; Amit Dhamoon; Wendy R Kates
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-05       Impact factor: 8.829

9.  Verbal short-term memory in individuals with chromosome 22q11.2 deletion: specific deficit in serial order retention capacities?

Authors:  Steve Majerus; Martial Van der Linden; Vérane Braissand; Stephan Eliez
Journal:  Am J Ment Retard       Date:  2007-03

10.  A gender-moderated effect of a functional COMT polymorphism on prefrontal brain morphology and function in velo-cardio-facial syndrome (22q11.2 deletion syndrome).

Authors:  Wendy R Kates; Kevin M Antshel; Nuria Abdulsabur; Deirdre Colgan; Birgit Funke; Wanda Fremont; Anne Marie Higgins; Raju Kucherlapati; Robert J Shprintzen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-04-05       Impact factor: 3.568

View more
  11 in total

1.  Cortical gyrification in velo-cardio-facial (22q11.2 deletion) syndrome: a longitudinal study.

Authors:  Arun Kunwar; Seethalakshmi Ramanathan; Joshua Nelson; Kevin M Antshel; Wanda Fremont; Anne Marie Higgins; Robert J Shprintzen; Wendy R Kates
Journal:  Schizophr Res       Date:  2012-02-22       Impact factor: 4.939

2.  Altered Brain Structure-Function Relationships Underlie Executive Dysfunction in 22q11.2 Deletion Syndrome.

Authors:  Rachel K Jonas; Maria Jalbrzikowski; Caroline A Montojo; Arati Patel; Leila Kushan; Carolyn C Chow; Therese Vesagas; Carrie E Bearden
Journal:  Mol Neuropsychiatry       Date:  2015-12-04

3.  Anxiety Disorders and Perceptual Disturbances in Adolescents with 22q11.2 Deletion Syndrome Treated with SSRI: A Case Series.

Authors:  Andrea C Stachon; Claire De Souza
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-11

4.  Longitudinal study of cerebral surface morphology in youth with 22q11.2 deletion syndrome, and association with positive symptoms of psychosis.

Authors:  Petya D Radoeva; Ravi Bansal; Kevin M Antshel; Wanda Fremont; Bradley S Peterson; Wendy R Kates
Journal:  J Child Psychol Psychiatry       Date:  2016-10-27       Impact factor: 8.982

5.  The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.

Authors:  Julia A Scott; Naomi Goodrich-Hunsaker; Kristopher Kalish; Aaron Lee; Michael R Hunsaker; Cynthia M Schumann; Owen T Carmichael; Tony J Simon
Journal:  J Psychiatry Neurosci       Date:  2016-04       Impact factor: 6.186

6.  A longitudinal examination of the psychoeducational, neurocognitive, and psychiatric functioning in children with 22q11.2 deletion syndrome.

Authors:  Stephen R Hooper; Kathleen Curtiss; Kelly Schoch; Matcheri S Keshavan; Andrew Allen; Vandana Shashi
Journal:  Res Dev Disabil       Date:  2013-03-16

Review 7.  22q11 deletion syndrome: a review of the neuropsychiatric features and their neurobiological basis.

Authors:  Chiara Squarcione; Maria Chiara Torti; Fabio Di Fabio; Massimo Biondi
Journal:  Neuropsychiatr Dis Treat       Date:  2013-12-04       Impact factor: 2.570

8.  Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion.

Authors:  J Ellegood; S Markx; J P Lerch; P E Steadman; C Genç; F Provenzano; S A Kushner; R M Henkelman; M Karayiorgou; J A Gogos
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

9.  Structural abnormalities in cortical volume, thickness, and surface area in 22q11.2 microdeletion syndrome: Relationship with psychotic symptoms.

Authors:  Maria Jalbrzikowski; Rachel Jonas; Damla Senturk; Arati Patel; Carolyn Chow; Michael F Green; Carrie E Bearden
Journal:  Neuroimage Clin       Date:  2013-10-14       Impact factor: 4.881

10.  Polymorphisms in MIR137HG and microRNA-137-regulated genes influence gray matter structure in schizophrenia.

Authors:  C Wright; C N Gupta; J Chen; V Patel; V D Calhoun; S Ehrlich; L Wang; J R Bustillo; N I Perrone-Bizzozero; J A Turner
Journal:  Transl Psychiatry       Date:  2016-02-02       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.